hypoxic imaging for brain tumor with 18F-fluoromisonidazole PET

hypoxic imaging for brain tumor with 18F-fluoromisonidazole PET - FMISO-PET for brain tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042213

Enrollment

170

Registered

2020-12-01

Start date

2020-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor

Interventions

Acquisition of 18F-fluoromisonidazole PET with PET/CT or PET/MRI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suspected to have brain tumors

Exclusion criteria

Exclusion criteria: (1) unstable patients (2) pediatric patients without their caregivers (3) pregnant patients in her 1st trimester

Design outcomes

Primary

Measure	Time frame
diagnostic performance	—

Countries

Japan

Contacts

Public ContactAkihiko Sakata

Kyoto University Hospital Department of Diagnostic Imaging and Nuclear Medicine

asakata@kuhp.kyoto-u.ac.jp0757513760

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026